A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells
Abstract New variants in the SARS‐CoV‐2 pandemic are more contagious (Alpha/Delta), evade neutralizing antibodies (Beta), or both (Omicron). This poses a challenge in vaccine development according to WHO. We designed a more universal SARS‐CoV‐2 DNA vaccine containing receptor‐binding domain loops fr...
Main Authors: | Sofia Appelberg, Gustaf Ahlén, Jingyi Yan, Negin Nikouyan, Sofie Weber, Olivia Larsson, Urban Höglund, Soo Aleman, Friedemann Weber, Emma Perlhamre, Johanna Apro, Eva‐Karin Gidlund, Ola Tuvesson, Simona Salati, Matteo Cadossi, Hanna Tegel, Sophia Hober, Lars Frelin, Ali Mirazimi, Matti Sällberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2022-10-01
|
Series: | EMBO Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.15252/emmm.202215821 |
Similar Items
-
DNA electroporation in a vacuum: A “shocking” innovation for vaccines
by: Noelia Silva-Pilipich, et al.
Published: (2024-03-01) -
Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model
by: Ami Patel, et al.
Published: (2021-10-01) -
A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever
by: Kathleen A. Cashman, et al.
Published: (2017-12-01) -
Recent Developments in Preclinical DNA Vaccination
by: Kenji Okuda, et al.
Published: (2014-01-01) -
Development, analysis, and preclinical evaluation of inactivated vaccine candidate for prevention of Covid-19 disease
by: Engin Alp Onen, et al.
Published: (2022-12-01)